Speaker illustration

Doctor Tymon Pol

Uppsala University, Uppsala (Sweden)

Member of:

European Society of Cardiology
Heart Failure Association

Low apolipoprotein a1 is significantly associated with decreased risk of cardiovascular events in anticoagulated patients with atrial fibrillation: insights from the ARISTOTLE trial.

Event: ESC CONGRESS 2017

Topic: Atrial fibrillation (AF)

Session: Atrial fibrillation obesity

Thumbnail

ESC 365 is supported by

logo Novo Nordisk